Intranasal delivery of agents to the brain, Adult stems cells and Insulin for treatment of brain injury and degenerative diseases, Possible effects of COVID-19 on the brain, long term complications, and policy choices.
Dr. William H. Frey II is a Senior Research Director of the Center for Memory & Aging at the HealthPartners Neuroscience Center in St. Paul, Minnesota. Dr. Frey’s focus has been the use of a non-invasive intranasal method for bypassing the blood-brain barrier to target therapeutic agents to the brain to treat neurological and psychiatric disorders while reducing unwanted side effects. These conditions include Mild Cognitive Impairment, Stroke, Traumatic Brain Injury, Posttraumatic Stress Disorder, Multiple Sclerosis, Alzheimer's, Parkinson's disease, and other brain diseases. He is also a faculty member in the Graduate Program in Neuroscience at the University of Minnesota. He can be reached at neuroresearch@healthpartners.com / 651-254-3736

---

This episode is sponsored by
· Anchor: The easiest way to make a podcast. https://anchor.fm/app

---

Send in a voice message: https://anchor.fm/scientificsense/message
Support this podcast: https://anchor.fm/scientificsense/support